Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (20), 6159-69
- https://doi.org/10.3748/wjg.v20.i20.6159
Abstract
Liver transplantation (LT) is the best treatment for end-stage hepatic failure, with an excellent survival rates over the last decade. Biliary complications after LT pose a major challenge especially with the increasing number of procured organs after circulatory death. Ischaemic cholangiopathy (IC) is a set of disorders characterized by multiple diffuse strictures affecting the graft biliary system in the absence of hepatic artery thrombosis or stenosis. It commonly presents with cholestasis and cholangitis resulting in higher readmission rates, longer length of stay, repeated therapeutic interventions, and eventually re-transplantation with consequent effects on the patient's quality of life and increased health care costs. The pathogenesis of IC is unclear and exhibits a higher prevalence with prolonged ischaemia time, donation after circulatory death (DCD), rejection, and cytomegalovirus infection. The majority of IC occurs within 12 mo after LT. Prolonged warm ischaemic times predispose to a profound injury with a subsequently higher prevalence of IC. Biliary complications and IC rates are between 16% and 29% in DCD grafts compared to between 3% and 17% in donation after brain death (DBD) grafts. The majority of ischaemic biliary lesions occur within 30 d in DCD compared to 90 d in DBD grafts following transplantation. However, there are many other risk factors for IC that should be considered. The benefits of DCD in expanding the donor pool are hindered by the higher incidence of IC with increased rates of re-transplantation. Careful donor selection and procurement might help to optimize the utilization of DCD grafts.Keywords
This publication has 99 references indexed in Scilit:
- Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up from a Single CenterAmerican Journal of Transplantation, 2009
- Donor Postextubation Hypotension and Age Correlate With Outcome After Donation After Cardiac Death TransplantationTransplantation, 2008
- Factors Affecting Graft Survival After Adult/Child Split-Liver Transplantation: Analysis of the UNOS/OPTN Data BaseAmerican Journal of Transplantation, 2008
- Biliary Complications After Liver Transplantation From Maastricht Category-2 Non-Heart-Beating DonorsTransplantation, 2008
- Factors Affecting Graft Survival After Liver Transplantation from Donation After Cardiac Death DonorsTransplantation, 2006
- Ischemic cholangiopathyJournal of Hepatology, 2006
- Recipient HLA-DR3, tumour necrosis factor-α promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are inter-related risk factors for chronic rejection of liver graftsJournal of Hepatology, 2001
- Immune Cholangitis: Liver Allograft Rejection and Graft-Versus-Host DiseaseMayo Clinic Proceedings, 1998
- Preservation of human liver grafts in UW solution. Ultrastructural evidence for endothelial and Kupffer cell activation during cold ischemia and after ischemia‐reperfusionLiver International, 1994
- A model for provoking ischemic necrosis in rat liver parenchyma and its quantitative analysisExperimental pathology, 1982